Skip to content

Inhaled Bronchodilator Association and Quality of Life in Patients With Chronic Obstructive Pulmonary Disease

COPD, Inhaled Bronchodilators Association, and Quality of Life

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02176564
Enrollment
2639
Registered
2014-06-27
Start date
1999-06-30
Completion date
Unknown
Last updated
2014-07-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary Disease, Chronic Obstructive

Brief summary

A pharmaco-epidemiological, observational study that aimed at assessing in a prospective manner the evolution of Quality of Life (QOL) in chronic obstructive pulmonary disease (COPD) patients treated with inhaled bronchodilators

Interventions

Sponsors

Boehringer Ingelheim
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Diagnosis of COPD confirmed by Pulmonary Function Test (PFTs) * Recent treatment with a free or fixed association of inhaled bronchodilators

Design outcomes

Primary

MeasureTime frame
Assessment of health-related quality of life (Short-Form Health Survey)4 months

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026